Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid Leukemia
Alicia M. Cole(Princess Margaret Cancer Centre), Zezhou Wang(Princess Margaret Cancer Centre), Étienne Coyaud(Princess Margaret Cancer Centre), Véronique Voisin(University of Toronto), Marcela Gronda(Princess Margaret Cancer Centre), Yulia Jitkova(Princess Margaret Cancer Centre), Rachel Mattson(Princess Margaret Cancer Centre), Rose Hurren(Princess Margaret Cancer Centre), Sonja Babovic(BC Cancer Agency), Neil MacLean(Princess Margaret Cancer Centre), Ian J. Restall(Princess Margaret Cancer Centre), Xiaoming Wang(Princess Margaret Cancer Centre), Danny V. Jeyaraju(Princess Margaret Cancer Centre), Mahadeo A. Sukhai(Princess Margaret Cancer Centre), Swayam Prabha(Princess Margaret Cancer Centre), Shaheena Bashir(University of Toronto), Ashwin Ramakrishnan(Princess Margaret Cancer Centre), Elisa Leung(University of Toronto), Yi Hua Qia(The University of Texas MD Anderson Cancer Center), Nianxian Zhang(The University of Texas MD Anderson Cancer Center), Kevin R. Combes(The University of Texas MD Anderson Cancer Center), Troy Ketela(Occupational Cancer Research Centre), Fengshu Lin(Princess Margaret Cancer Centre), Walid A. Houry(University of Toronto), Ahmed Aman(Ontario Institute for Cancer Research), Rima Al‐awar(Ontario Institute for Cancer Research), Wei Zheng(National Institutes of Health), Erno Wienholds(University of Toronto), Chang Xu(University of Toronto), John E. Dick(University of Toronto), Jean Wang(University of Toronto), Jason Moffat(Occupational Cancer Research Centre), Mark D. Minden(University of Toronto), Connie J. Eaves(BC Cancer Agency), Gary D. Bader(University of Toronto), Zhenyue Hao(Princess Margaret Cancer Centre), Steven M. Kornblau(The University of Texas MD Anderson Cancer Center), Brian Raught(Princess Margaret Cancer Centre), Aaron D. Schimmer(University of Toronto)
Cited by 346Open Access